Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
Preventive healthcare use among males with multiple sclerosis.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
Modeling the heterogeneity of multiple sclerosis in animals.
Major stressful life events in adulthood and risk of multiple sclerosis.
Added benefit of fampridine is not proven
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Epstein-Barr virus, latitude and multiple sclerosis.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Pages
« first
‹ previous
…
150
151
152
153
154
155
156
157
158
…
next ›
last »